Juvena Therapeutics Secures $41 Million To Accelerate The Discovery And Development Of Biologics For Chronic And Age-Related Diseases
Amount Raised
$41 Million
Round Type
Funding Round
Palo AltoInformation TechnologyBiotechnologyTherapeuticsDescription
Juvena Therapeutics, Inc. (“Juvena”), a biotechnology company scaling a computational platform to map the therapeutic potential of secreted proteins, announced today that it has raised $41 million in an oversubscribed Series A, bringing its total funding to $50 million. The new funding will power the expansion of Juvena’s drug discovery platform and advance the company’s biologics pipeline targeting chronic and age-related diseases.
Quick answer
Juvena Therapeutics raised $41 Million in a Funding Round round, dated November 8, 2022. Juvena Therapeutics is based in Palo Alto, California, United States.
- How much did Juvena Therapeutics raise?
- Juvena Therapeutics raised $41 Million in a Funding Round round on November 8, 2022.
- What does Juvena Therapeutics do?
- Juvena Therapeutics is a biotech company accelerating the development of therapeutics by unlocking the therapeutic potential of secreted proteins.
- Where is Juvena Therapeutics based and how big is it?
- Juvena Therapeutics is based in Palo Alto, California, United States. Fundz records about 45 employees.
- Who are the decision-makers at Juvena Therapeutics?
- Fundz holds 1 contact at Juvena Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Juvena Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- GenSight Biologics raised $13M (Convertible Note) on December 23, 2022.
- Biomica raised $20M (Funding Round) on December 21, 2022.
- Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
- QurAlis raised $60M on December 20, 2022.
- Gallant raised $25M on December 15, 2022.
- Alpha-9 Theranostics raised $75M (Series B) on December 14, 2022.
Who to call at Juvena Therapeutics, and when
A new round usually means Juvena Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Juvena Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Juvena Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Juvena Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Juvena Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Juvena Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.